Literature DB >> 380868

Effect of diclofenac and naproxen on gastroduodenal mucosa.

M Osnes, S Larsen, W Eidsaunet, E Thom.   

Abstract

The increases in medan scoresfluence on gastroduodenal mucosa of naproxen, 500 mg/day, and diclofenac, 100 mg/day, for 1 wk was investigated in 14 subjects in a double-blind randomized crossover study. Endoscopic examination of the gastroduodenal mucosa was carried out before and after each drug with regard to gastritis and hemorrhagic and erosive lesions. A 20-cm visual analogue scale was used for grading severity of mucosal changes. Naproxen caused statistically significant increases inmedian scores for all 3 variables, and 10 subjects showed a score increase in at least 1 variable; reaction to diclofenac occurred in only 4 subjects and the changes in median scores were not significant.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 380868     DOI: 10.1002/cpt1979263399

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  7 in total

1.  Placebo-controlled comparison of piroxicam-beta-cyclodextrin, piroxicam, and indomethacin on gastric potential difference and mucosal injury in humans.

Authors:  L Santucci; S Fiorucci; S Chiucchiù; A Sicilia; L Bufalino; A Morelli
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

2.  A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors.

Authors:  C Brideau; S Kargman; S Liu; A L Dallob; E W Ehrich; I W Rodger; C C Chan
Journal:  Inflamm Res       Date:  1996-02       Impact factor: 4.575

3.  Treatment of the restless legs syndrome with carbamazepine: a double blind study.

Authors:  W Telstad; O Sørensen; S Larsen; P E Lillevold; P Stensrud; R Nyberg-Hansen
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-11

Review 4.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

Review 5.  Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin.

Authors:  R N Brogden; R C Heel; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-07       Impact factor: 9.546

6.  Inter-observer agreement in the assessment of endoscopic findings in ulcerative colitis.

Authors:  Thomas de Lange; Stig Larsen; Lars Aabakken
Journal:  BMC Gastroenterol       Date:  2004-05-18       Impact factor: 3.067

Review 7.  Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology.

Authors:  Roy Altman; Bill Bosch; Kay Brune; Paola Patrignani; Clarence Young
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.